AdvaMed issues pandemic compliance guidance for med-tech
By 
Jaclyn Jaeger2020-05-15T15:26:00
The Advanced Medical Technology Association has released new compliance guidance for medical-technology companies to guide them in mitigating compliance and corruption risks as they help healthcare providers fight coronavirus.
Related articles
-
ArticleNavigating the return of employees to the workplace
Bringing employees back from working from home means reacting to ever-changing recommendations from health experts as well as the mandates of state and local officials.
-
ArticleDo we have to give up our privacy to be safe from coronavirus?
How much of your privacy rights and civil liberties are you willing to give up in the fight against the coronavirus pandemic? Our collective answer might determine how successful we are in the next phase of this fight.
-
ArticleSo your company’s CEO has coronavirus. Does the world have to know?
As infections stemming from the coronavirus pandemic continue to mount around the world, publicly traded companies face questions about when and where to disclose that their CEO or other key executives have contracted the virus.
More from Risk Management
-
PodcastStudy: Compliance managers must set rules in race to adopt AI agents and copilots
More than half of all compliance teams are “actively using” or “piloting” AI applications, according to a Moody’s report. While most are focusing on streamlining routine tasks, some are developing AI agents and asking vital questions about AI decision-making.
-
PremiumThanks to 'laser focus' on cartels, Trump admin creates new corporate risks in Mexico
The Trump administration’s designation of Mexican cartels as terrorist organizations in February has made doing business in Mexico riskier than ever before for corporations.
-
News BriefFederal Reserve Board drops reputational risk from exams, aligning with OCC and FDIC shift
Bank examiners at the Federal Reserve Board will no longer assess reputational risk during examinations, a concession to the banking industry already underway with two other U.S. regulators.